Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8355291 | 0.97 | CA2 (0.32) | CA2 | |
| SCHEMBL196347 | 0.82 | CA2 (0.40) | CA2 | |
| SCHEMBL1034296 | 0.78 | — | — | |
| SCHEMBL15370209 | 0.76 | CA2 (0.32) | CA2 | |
| SCHEMBL1695072 | 0.75 | — | — | |
| SCHEMBL14616651 | 0.74 | CA2 (0.35) | CA2 | |
| SCHEMBL7114391 | 0.74 | CA2 (0.35) | CA2 | |
| SCHEMBL14488048 | 0.72 | CA2 (0.33) | CA2 | |
| SCHEMBL333428 | 0.72 | CA2 (0.33) | CA2 | |
| SCHEMBL15455943 | 0.72 | LMNA (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-58217921-A | — | — | None | — | — | JP | disclosed |
| US-10835895-B2 | Compound and synthesis method therefor | THE UNIVERSITY OF TOKYO (JP) | 2020-11-17 | — | — | US | disclosed |
| CN-110800150-A | Non-aqueous electrolyte and electrolytic solution containing electrolyte stabilizing material, secondary battery containing the same, and use thereof | 株式会社村田制作所 | 2020-02-14 | — | — | CN | disclosed |
| US-20190111418-A1 | COMPOUND AND SYNTHESIS METHOD THEREFOR | THE UNIVERSITY OF TOKYO (JP) | 2019-04-18 | — | — | US | disclosed |
| US-20170253623-A1 | IRIDIUM COMPLEX PRODUCTION METHOD | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2017-09-07 | — | — | US | disclosed |
| US-20170192010-A1 | COMPOSITIONS AND METHODS FOR DETECTING PROTEIN SULFENYLATION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2017-07-06 | — | — | US | disclosed |
| EP-2468801-B1 | PROCESS FOR PRODUCING THERMOPLASTIC RESIN COMPOSITION, MOLDED OBJECT, AND LUMINESCENT OBJECT | MITSUBISHI RAYON CO (JP) | 2017-04-26 | — | — | EP | disclosed |
| WO-2015118561-A1 | PROCESSES FOR PRODUCING 1,1,1,5,5,5 HEXAFLUOROACETYL ACETONE | SRF LIMITED (IN) | 2015-08-13 | — | — | WO | disclosed |
| US-8889785-B2 | Production method of thermoplastic resin composition, molded body, and light emission body | MITSUBISHI RAYON CO., LTD. (JP) | 2014-11-18 | — | — | US | disclosed |
| US-20120214922-A1 | PRODUCTION METHOD OF THERMOPLASTIC RESIN COMPOSITION, MOLDED BODY, AND LIGHT EMISSION BODY | MITSUBISHI RAYON CO., LTD. (JP) | 2012-08-23 | — | — | US | disclosed |
| EP-2468801-A1 | PROCESS FOR PRODUCING THERMOPLASTIC RESIN COMPOSITION, MOLDED OBJECT, AND LUMINESCENT OBJECT | Mitsubishi Rayon Co., Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| US-4981836-A | Recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1991-01-01 | — | — | US | disclosed |
| JP-S58217921-A | TRANSMISSION TYPE SCREEN | SONY CORP | 1983-12-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170192010-A1 | COMPOSITIONS AND METHODS FOR DETECTING PROTEIN SULFENYLATION | PTMS, QSOX1, PRDX3 | CA2 915/4885 |
| US-20170253623-A1 | IRIDIUM COMPLEX PRODUCTION METHOD | IPMK, TALDO1, BCKDK | CA2 455/4885 |
| US-10835895-B2 | Compound and synthesis method therefor | GOT1, GOT2, SLC39A11 | CA2 1663/4885 |
| US-20190111418-A1 | COMPOUND AND SYNTHESIS METHOD THEREFOR | GOT1, GOT2, SLC39A11 | CA2 1602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.